Leptospirosis in the United States

Abstract
THE most recent comprehensive review of leptospirosis in the United States was presented by Molner, Meyer and Raskin1 in 1948. Since that time, knowledge concerning the epidemiologic and clinical characteristics of leptospirosis in this country has greatly expanded. Numerous pathogenic leptospiral serotypes have now been demonstrated in a broad range of animal hosts, both domestic and wild.2 3 4 5 6 Improved procedures in laboratory diagnosis have become more widely available and have greatly facilitated the detection of leptospiral infection. In addition, the medical profession has grown increasingly aware that the clinical manifestations of human leptospirosis are by no means limited to the relatively . . .